{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:06:24Z","timestamp":1772780784047,"version":"3.50.1"},"reference-count":13,"publisher":"BMJ","issue":"6772","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1991,2,9]]},"DOI":"10.1136\/bmj.302.6772.313","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"313-316","source":"Crossref","is-referenced-by-count":13,"title":["Integration of hepatitis B vaccination into rural African primary health care programmes."],"prefix":"10.1136","volume":"302","author":[{"given":"B D","family":"Schoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"McAnerney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Kew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N D","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/clinids\/11.Supplement_3.S574","article-title":"(ilobal control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization","volume":"3","author":"Maynard, J.E.; Kane, M.A.; Hadler, S.C.","year":"1989","unstructured":"Maynard JE, Kane MA, Hadler SC. (ilobal control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization. Rev, In-fect Dis 1989;llksuppl 3):S574-8.","journal-title":"Rev, In-fect Dis"},{"key":"ref_2","first-page":"\"S\" # \"2597","article-title":"Strategies f'or viral immunization in South Africa-augmentation of EPI","volume":"257","author":"Schoub, B.D.; Johnson, S.; McAnerney, J.I.M.; Wagstaff, L.","year":"1988","unstructured":"Schoub BD, Johnson S, McAnerney JIM, Wagstaff L. Strategies f'or viral immunization in South Africa-augmentation of EPI. In: Koornhof HJ, Wadee AA, eds. Health for all by the year 2000: proceedings of the symposium on infections itn developing counmries. Cape Towni: South African Medical Research Counicil, 1988. S Chen D-S, Hsu NH-Mi, Sung J-L, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigencarrier mothers. JAMA 1987;257:2597-603.","journal-title":"South African Medical Research Counicil; Health for all by the year 2000: proceedings of the symposium on infections itn developing counmries. Cape Towni"},{"key":"ref_3","first-page":"65","article-title":"The hepatitis B immunization programme in Singapore","volume":"67","author":"Goh, K.T.; Doraisingham, S.; Tan, K.L.","year":"1989","unstructured":"Goh KT, Doraisingham S, Tan KL, et al. The hepatitis B immunization programme in Singapore. Bull WHO 1989;67:65-70.","journal-title":"Bull WHO"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(86)90543-X","article-title":"Seven-year study of hepatitis B vaccine efficacv in infants from an endemic area (Senegal)","volume":"ii:","author":"Coursaget, P.; Chotard, J.; Vincelot, P.","year":"1986","unstructured":"Coursaget P, Chotard J, Vincelot P, et al. Seven-year study of hepatitis B vaccine efficacv in infants from an endemic area (Senegal). Lancet 1986;ii: 1143-5.","journal-title":"Lancet"},{"key":"ref_5","first-page":"1057","article-title":"Hepatitis B vaccine in the expanded programme of immunisation: the Gambian experience","volume":"i:","author":"Hall, A.J.; Inskip, H.M.; Loik, F.","year":"1989","unstructured":"Hall AJ, Inskip HM, Loik F, et al. Hepatitis B vaccine in the expanded programme of immunisation: the Gambian experience. Lancet 1989;i: 1057-60.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/oxfordjournals.aje.a115102","article-title":"Regional prevalence of hepatitis B, delta, and humaii immunodeficiencsy virus infection in southern Africa: a large population survesy","volume":"129","author":"Dusheiko, G.M.; Brink, B.A.; Conradie, J.D.; Marimuthu, T.; Sher, R.","year":"1989","unstructured":"Dusheiko GM, Brink BA, Conradie JD, Marimuthu T, Sher R. Regional prevalence of hepatitis B, delta, and humaii immunodeficiencsy virus infection in southern Africa: a large population survesy. Am J Epidemiol 1989;129: 138-45.","journal-title":"Am J Epidemiol"},{"key":"ref_7","article-title":"Children's Fund (Unicef). The state o)fthe world's children","author":"United Nations","year":"1987","unstructured":"United Nations Children's Fund (Unicef). The state o)fthe world's children. New York: Oxford University Press, 1987."},{"issue":"1","key":"ref_8","first-page":"1","article-title":"The case for routine hepatitis B immunization in infancy for populations at increased risk","volume":"6","author":"Smego, R.A.; Halsey, N.A.","year":"1987","unstructured":"Smego RA, Halsey NA. The case for routine hepatitis B immunization in infancy for populations at increased risk. PediatrInjectDtsJ 1987;6:1 1-9.","journal-title":"PediatrInjectDtsJ"},{"key":"ref_9","first-page":"891","article-title":"Baseline epidemiological studies for hepatitis B saccine trial in Kangwane","volume":"64","author":"Prozeskv, O.W.; Szmuness, W.; Stevens, C.E.","year":"1983","unstructured":"Prozeskv OW, Szmuness W, Stevens CE, et al. Baseline epidemiological studies for hepatitis B saccine trial in Kangwane. S 4fr Med J 1983;64: 891-3.","journal-title":"S 4fr Med J"},{"key":"ref_10","first-page":"1210","article-title":"Hepatitis B virus carrier state in black children in Ovarnboland: role of perinatal and horizontal infection","volume":"i:","author":"Botha, J.F.; Ritchie, M.J.J.; Dusheiko, G.M.; Miouton, H.W.K.; Kew, M.C.","year":"1984","unstructured":"Botha JF, Ritchie MJJ, Dusheiko GM, Miouton HWK, Kew MC. Hepatitis B virus carrier state in black children in Ovarnboland: role of perinatal and horizontal infection. Lancet 1984;i: 1210-2.","journal-title":"Lancet"},{"issue":"132","key":"ref_11","article-title":"Mass saccination against hcpatitis B in infants in Italy","volume":"1","author":"Piazza, M.; V'illa, Da; G, Picciotto; L.","year":"1988","unstructured":"Piazza M, Da V'illa G, Picciotto L, et al. Mass saccination against hcpatitis B in infants in Italy. Lancet 1988;ii: 1 132.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0140-6736(87)91255-4","article-title":"HBsAg positive reactivity in man not due to hepatitis B sirus","volume":"ii:","author":"Coursaget, P.; Bourdil, C.; Adamowicz, P.","year":"1987","unstructured":"Coursaget P, Bourdil C, Adamowicz P, et al. HBsAg positive reactivity in man not due to hepatitis B sirus. Lancet 1987;ii: 1354-8.","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/IAI.51.3.784-787.1986","article-title":"Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization programme: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B stirface antigen","volume":"51","author":"Coursaget, P.; Yvonnet, B.; Relyveld, E.H.","year":"1986","unstructured":"Coursaget P, Yvonnet B, Relyveld EH, et al. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization programme: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B stirface antigen. Infect Immun 1986;51: 784-7.","journal-title":"Infect Immun"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.302.6772.313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:21:33Z","timestamp":1601108493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.302.6772.313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2,9]]},"references-count":13,"journal-issue":{"issue":"6772","published-print":{"date-parts":[[1991,2,9]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.302.6772.313","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,2,9]]}}}